Derived from a single traditional Chinese medicine (TCM) plant

Potent antitussive action

No known side effect observed in the Phase I/II study

Awarded as one of the Benchmark Projects in Taiwan (selected by the Taiwanese regulatory authority, Center for Drug Evaluation)

GCP-compliant Phase I/II clinical study completed in Taiwan

US FDA IND approved for the subsequent clinical trial

Phase II clinical study completed